First Tracks Biotherapeutics, Inc. (TRAX)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 5, 2026

Verified against EDGAR
Total Assets
$183.1M
Stockholders' Equity
$168.8M
Cash & Equivalents
$168.0M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, First Tracks Biotherapeutics, Inc. reported net income of -$33.4M and total assets of $183.1M. Every figure below is taken directly from First Tracks Biotherapeutics, Inc.'s SEC filings: each links to the source document on EDGAR.

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
S-1Oct 26, 2026on EDGAR ↗
8-KOct 20, 2026on EDGAR ↗
8-KOct 15, 2026on EDGAR ↗
8-KOct 13, 2026on EDGAR ↗
8-KAug 12, 2026on EDGAR ↗
10-QAug 12, 2026on EDGAR ↗
8-KJun 22, 2026on EDGAR ↗
8-KMay 14, 2026on EDGAR ↗
10-QMay 14, 2026on EDGAR ↗
S-1May 8, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$183.1Msource ↗
Stockholders’ Equity$168.8Msource ↗
Cash & Equivalents$168.0Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$33.4Msource ↗
Operating Income-$34.9Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$25.6Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.95source ↗
EPS (basic)$-0.95source ↗
Shares Outstanding35.7Msource ↗
Cash from Operations-$31.9Msource ↗
Cash from Financing-$48.5Msource ↗
Cash from Investing-$25,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
1
Net shares
-39.3K

Restatement history

Point-in-time

No material restatements detected across 0 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches TRAX’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/TRAX

MCP tool: get_sec_fundamentals ticker=TRAX

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/TRAX/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=TRAX as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/TRAX/history

MCP tool: get_fundamentals_history ticker=TRAX

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/TRAX

MCP tool: get_financial_health ticker=TRAX

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.